LLY

NYSE · Pharmaceuticals

Eli Lilly and Co.

S&P 500 Mega-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks

$1,189.35

+19.49 (+1.67%)

As of Aug 6, 9:30 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Very High

Coverage

Buy 30 79%

Hold 7 18%

Sell 1 3%

Price Target

Analyst Price Target +11.9% upside

Low Target $960.24

Average Target $1,330.33

High Target $1,470.76

Current Price $1,189.35

Current
$1,189.35

Target
$1,330.33

$960.24 $1,330.33 avg $1,470.76

Scenario Analysis

Bear Case

$960.24

-19.3%

Low target

Base Case

$1,330.33

+11.9%

Avg target

Bull Case

$1,470.76

+23.7%

High target

Risk/Reward

1.2x

Balanced

Price in Context

52-Week High

$1,249.45

-4.8% from high

52-Week Low

$623.78

+90.7% from low

50-Day SMA

$1,141.44

+4.2% vs SMA

200-Day SMA

$1,021.54

+16.4% vs SMA

RSI (14)

48.5

Neutral

Target vs 52W High

$1,330.33

+6.5% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+11.9%
RDY Dr. Reddy's Laboratories	Sell	44	52%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+16.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.8%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+30.5%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+172.3%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.7%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+173.7%